Diagnostics & Diseases Market Research Reports & Industry Analysis

... market entrants identify and evaluate emerging opportunities in the European blood banking market during the next five years, and to assist industry ... ; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than ...

... other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and evaluates major ... disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. ...

... ; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic ...

... testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, continuing contraction ...

... potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal ...

... companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business ... the main driving forces behind the growth of this dynamic market is continuous spread of AIDS, which remains the world’s major health ...

... introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and ...

... cytometry markets, including: Major issues pertaining to the Italian hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological ... the next ten years. Five and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed ...

... report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key ... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for 40 cancer diagnostic procedures performed ...

... significant market impact during the next ten years. Five and ten-year volume and sales forecasts for over 100 clinical ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and emerging ...

This report presents a comprehensive analysis of the UK coagulation market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...

This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...

... cytometry markets, including: Major issues pertaining to the Spanish hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological ... the next ten years. Five and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed ...

This report presents a comprehensive analysis of the US infectious disease testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current ...

This report presents a comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

This report presents a comprehensive analysis of the German molecular diagnostics market, including: Major issues pertaining to the German molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

This report presents a comprehensive analysis of the Italian molecular diagnostics market, including: Major issues pertaining to the Italian molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including: Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

This report presents a comprehensive analysis of the UK molecular diagnostics market, including: Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten ...

Cardiac rhythm management (CRM) is a well established segment of the cardiology devices market. CRM devices are commonly used for the treatment of arrhythmias and ...

... Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in ... basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly ...

... and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The ... forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and ...

... opportunities and developing effective business strategies. The report provides market segmentation analysis of over 70 diseases and viruses in major European countries (France, Germany, Italy, Spain, UK); assessment of emerging technologies; review of current instrumentation; as well as strategic profiles ...

This new report from Venture Planning Group provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood ...

This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood ...

This new report from Venture Planning Group provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

This new report from Venture Planning Group provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

This new report from Venture Planning Group provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: ...

This new report from Venture Planning Group provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

This new report from Venture Planning Group provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: Blood Banking Cancer Chemistry Coagulation ...

... trends with significant market impact during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Five- ...

... . Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ... and their potential market applications. Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. Profiles of 25 current and ...

... and technological trends with significant market impact during the next five years. Five-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads. Placement estimates for major ...

This new 275-page report from Venture Planning Group contains 42 tables, and presents a comprehensive analysis of the US hematology and flow cytometry markets, including: Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and ...

This new 1,037-page report from Venture Planning Group contains 177 tables, and presents a comprehensive analysis of the US infectious disease testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends ...

... . Feature comparison of automated and semiautomated analyzers. Sales and market shares of leading suppliers. Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products. Profiles of major suppliers, and emerging market entrants, including their sales, ...

... - and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in US hospitals, commercial laboratories, physician offices and ambulatory care centers. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and ...

This new 340-page report from Venture Planning Group provides analysis of the global blood banking market, including emerging tests, technologies, ... and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S. Comprehensive analysis of the clinical significance and market needs for major blood ...

... to be made in the future, and enhances corporate ability to develop realistic contingency plans. The report presents strategic overview of the U.S. in vitro diagnostics market, including major regulatory, economic, demographic and social trends with potentially significant impact as well as five - and ten- ...

... Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume ... coagulation procedures by market segment: Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine ...

... pharmacogenomics); and cancer screening/pharmacogenomics - are forecast to grow at CAGRs of 14%, 22%, 19% and 30% respectively. Your key questions answered Which micro and nano technologies in development offer the attributes of miniat What drivers and restraints operate in the nascent market for POC ...

This new 302-page report from Venture Planning Group provides analysis of the global coagulation testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of coagulation testing ...

This new 178-page report from Venture Planning Group provides analysis of the global hematology and flow cytometry market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated number of hematology ...

... Brazil. In their latest research study, “In-Vitro Diagnostics Market Analysis to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight ... that together constitute around 95% of the global market, have been profiled. Further, the market has been divided into eight distinct ...

... betting on vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the ...

... . Genetic testing market in India was initially limited to very few organizations in the country, which possessed both the expertise and the capability to conduct screening tests ... . The success of genetic testing in India depends on overcoming major challenges that span around this field. Since India is one of the emerging markets and being looked ...

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

This new report from Venture Planning Group provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements ...

... is mainly due to the potential R&D tax credit which will be realized from 1Q 2013. But beyond 2013, we see loss of Cymbalta sales to generic ... price. Despite the increasing growth of diabetes therapy, the revenues from Humulin and Humalog continued to be flat due to competition.

This new report from Venture Planning Group provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios ...